MarginsXMarginsX
Home › Markets › Industrials › CTKB

Cytek Biosciences Inc. (CTKB)

CTKB trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$5.63
-3.60% on the day
Market cap
$736.3M
Small cap
Revenue · 2025
$201.5M
+0.5% on 2024
Net income · 2025
-$66.5M
-33.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1831915/000162828026012352/0001628280-26-012352-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCTKB on Nasdaq
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
CountryUnited States
IPO year2021
SEC CIK0001831915
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$201.5M
Net income-$66.5M
Operating income-$40.4M
Net margin-33.0%
Operating margin-20.0%
Revenue growth+0.5%
Cash$90.9M
Total assets$461.5M
P/E (computed)Net income was not positive
P/S (computed)3.7×

Warning signs

Cash runway
121.6 months
$66.8M cash at September 30, 2026
Share count, 1 year
+2.3%
2025-10-31 to 2026-10-31 · -3.5% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$66.8M cash; operating cash flow -$1.6M a quarter.Report 2026-09-30
Shares outstanding130,783,967 (2026-10-31); 127,864,830 a year earlier; 135,549,154 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$53.2M-$6.1M-$4.5M$66.8MNo debt tags$207.6M10-Q 2026-11-04
Q2 2026
2026-06-30
$48.1M-$12.2M$1.4M$73.8MNo debt tags$206.7M10-Q 2026-08-05
Q1 2026
2026-03-31
$44.1M-$18.9M-$2.7M$65.7MNo debt tags$204.2M10-Q 2026-05-07
Q4 2025
2025-12-31
$62.1M-$44.1M-$771K$90.9MNo debt tags$201.5M10-K 2026-02-26
Q3 2025
2025-09-30
$52.3M-$5.5M-$3.9M$93.3MNo debt tags$196.8M10-Q 2026-11-04
Q2 2025
2025-06-30
$45.6M-$5.6M$108K$75.5MNo debt tags$196.0M10-Q 2026-08-05
Q1 2025
2025-03-31
$41.5M-$11.4M-$125K$95.3MNo debt tags$197.1M10-Q 2026-05-07
Q4 2024
2024-12-31
$57.5M$9.6M$2.0M$98.7MNo debt tags$200.5M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2022-08-26
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 466 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.2%
1 month+9.2%
3 months+19.4%
Year to date+15.6%
1 year+27.8%
From 52-week high-7.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Laboratory Analytical Instruments

TickerCompanyPriceDayMarket cap
PACBPacific Biosciences of California Inc.$1.84-6.12%$575.8M
NAUTNautilus Biotechnology Inc.$2.10-9.48%$267.5M
ALMRAlamar Biosciences Inc.$30.55-0.84%$2.1B
LABStandard BioTools Inc.$0.6210-12.21%$245.2M
QTRXQuanterix Corporation$2.84-3.07%$134.8M
SEERSeer Inc.$1.48-5.73%$82.6M
TXG10x Genomics Inc.$54.99-5.50%$7.2B
BRKRBruker Corporation$60.62-1.57%$9.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier